Dualsystems Biotech
Hybrigenics Acquires Dualsystems Biotech's Yeast Two-Hybrid Business
NEW YORK (GenomeWeb News) – Hybrigenics has acquired the yeast two-hybrid assets of Swiss biotech firm Dualsystems Biotech.
Growing Demand for Integrated Workflows Drives Formation of 13-Firm Proteomics Innovation Network
Premium
According to Matthew Kuruc, COO of PIN member ProFact Proteomics, the network aims to help smaller firms offer complete solutions similar to those increasingly provided by large instrument vendors and to popularize non-mass spec-based proteomics workflows.
Although it's too early to announce biopharma partners, the 13 companies involved in the network are hoping that their collective skills and specialties will attract companies interested in developing drugs targeted to specific proteomic markers in patients.
The group aims to provide solutions for all stages of proteomics research and address "critical unmet needs in biomarker and drug target discovery, personalized medicine, drug profiling, and selective reaction monitoring."
Bulldog Bio to Market Dualsystems' Protein Expression Wares in the US
The deal makes Bulldog the single source of Dualsystems' products in the US.
Dec 3, 2010